TriSalus Life Sciences, Inc.

NASDAQ:TLSI

Medical - Devices

Healthcare
$2.18 +0.49%

+$0.02 today

Market cap
$134.20M
Beta
0.49
P/E (TTM)
-7.4
EPS (TTM)
-$0.53
52W Low $2.20High $7.95

Volume 0.36M

Average 0.38M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$18.01M

FY 2025 · Annual

Investing Cash Flow

-$838,000.00

FY 2025 · Annual

Financing Cash Flow

$30.76M

FY 2025 · Annual

-18.9% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(28.85M)(47.19M)(59.36M)(30.05M)(39.23M)
Depreciation & Amortization464K398K684K744K626K
Deferred Income Tax00000
Stock-Based Compensation109K368K1.4M5.44M9.13M
Change in Working Capital(131K)2.3M537K(9.55M)2.07M
Accounts Receivables(741K)(200K)(1.98M)(1.72M)(1.63M)
Inventory(725K)(179K)(1.07M)(1.5M)971K
Accounts Payables3.18M5.25M2.84M(4.38M)2.02M
Other Working Capital(1.84M)(2.57M)751K(1.94M)711K
Other Non-Cash Items5.71M11.81M6.16M(7.43M)9.39M
Operating Cash Flow(22.7M)(32.31M)(50.58M)(40.84M)(18.01M)
Capital Expenditures(1.26M)(786K)(588K)(345K)(918K)
Acquisitions (Net)000080K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(1.16M)(1.13M)(1M)00
Investing Cash Flow(2.26M)(1.79M)(1.59M)(345K)(838K)
Debt Repayment(1.3M)(131K)(87K)24.92M9.92M
Common Stock Issued00015.54M22.91M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities54K94K45.53M(2.52M)(2.07M)
Financing Cash Flow50.77M13.46M54.63M37.94M30.76M
Effect of Forex Changes00000
Net Change in Cash25.81M(20.64M)2.46M(3.25M)11.91M
Free Cash Flow(23.96M)(33.1M)(51.17M)(41.19M)(18.93M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$39.2M
+ D&A$626.0K
+ Stock-Based Comp$9.1M
+ Deferred Tax$0
+ Working Capital$2.1M
+ Other Non-Cash$9.4M
= Operating Cash Flow-$18.0M
- Capex-$918.0K
= Free Cash Flow-$18.9M

Analysis

FY2025 free cash flow is -$18.9M. FCF conversion is 48.3% of net income. Operating cash flow was -$18.0M, with capex of -$918.0K. The largest bridge item is Other Non-Cash at $9.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026

Does TLSI generate free cash flow?

TriSalus Life Sciences, Inc. (TLSI) generated -$18.93M of free cash flow in fiscal 2025.

How much operating cash flow does TLSI produce?

Operating cash flow was -$18.01M, before capital expenditures of $918,000.00.